BLU-285

It’s a Journey: Our Experience on Clinical Trials

By Jennifer Moore, LRG Member I was waiting in line to pick up a new prescription for Gleevec when my husband ran in and told me to forget it. After two surgeries, a year [...]

By |2020-01-31T10:44:52-05:00December 28th, 2017|Clinical Trials, Member Stories, News, Newsletter|

GIST Patient Community Update on BLU-285 Clinical Program

Dr. Anthony Boral, Chief Medical Officer of Blueprint Medicines, provided an update on the clinical development of BLU-285, an investigational medicine being developed for patients with advanced GIST. The presentation included an [...]

By |2020-07-09T14:57:35-04:00July 6th, 2017|Clinical Trials, Video|

Update on Blueprint Medicines Clinical Trial for BLU-285

Recently a number of companies have begun to develop therapeutic options that target some of the rarer mutations in GIST. As there are currently no approved treatments specifically for these patients, this [...]

By |2019-07-03T10:45:21-04:00May 24th, 2016|Clinical Trials, News, Research|
Go to Top